Terms: = Breast cancer AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1 AND Diagnosis
12 results:
1. Health education actions on male breast cancer: A protocol for systematic review and meta analysis.
Silva JFCD; Torres GV; Reis LAD; Campos JTAM; Nunes VMA; Santos JCC; Barbalho TNS; Xavier Nobre TT
Medicine (Baltimore); 2022 Oct; 101(42):e30931. PubMed ID: 36281187
[TBL] [Abstract] [Full Text] [Related]
2. Disclosure of genetic risk to dating partners among young adults with von Hippel-Lindau disease.
Bond E; Yashar B; Else T; Osborne J; Marvin M
Fam Cancer; 2023 Apr; 22(2):203-215. PubMed ID: 35984582
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive analysis of germline mutations in northern Brazil: a panel of 16 genes for hereditary cancer-predisposing syndrome investigation.
Vidal AF; Ferraz RS; El-Husny A; Silva CS; Vinasco-Sandoval T; Magalhães L; Raiol-Moraes M; Barra WF; Pereira CLBL; de Assumpção PP; de Brito LM; Vialle RA; Santos S; Ribeiro-Dos-Santos Â; Ribeiro-Dos-Santos AM
BMC Cancer; 2021 Apr; 21(1):363. PubMed ID: 33827469
[TBL] [Abstract] [Full Text] [Related]
4. Combination of Immunomagnetic Separation with Aptamer-Mediated Double Rolling Circle Amplification for Highly Sensitive Circulating Tumor Cell Detection.
Sun S; Yang S; Hu X; Zheng C; Song H; Wang L; Shen Z; Wu ZS
ACS Sens; 2020 Dec; 5(12):3870-3878. PubMed ID: 33205648
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of an amplicon-based custom gene panel for the diagnosis of hereditary tumors.
Shinriki S; Maeshiro M; Shimamura K; Kawashima J; Araki E; Ibusuki M; Yamamoto Y; Iwase H; Miyamoto Y; Baba H; Yamaguchi M; Matsui H
Neoplasma; 2020 Jul; 67(4):898-908. PubMed ID: 32241160
[TBL] [Abstract] [Full Text] [Related]
6. Theranostic application of
Cava C; Novello C; Martelli C; Lodico A; Ottobrini L; Piccotti F; Truffi M; Corsi F; Bertoli G; Castiglioni I
Theranostics; 2020; 10(1):50-61. PubMed ID: 31903105
[TBL] [Abstract] [Full Text] [Related]
7. A hypoxia-responsive TRAF6-ATM-H2AX signalling axis promotes HIF1α activation, tumorigenesis and metastasis.
Rezaeian AH; Li CF; Wu CY; Zhang X; Delacerda J; You MJ; Han F; Cai Z; Jeong YS; Jin G; Phan L; Chou PC; Lee MH; Hung MC; Sarbassov D; Lin HK
Nat Cell Biol; 2017 Jan; 19(1):38-51. PubMed ID: 27918549
[TBL] [Abstract] [Full Text] [Related]
8. Uptake of prenatal diagnostic testing for retinoblastoma compared to other hereditary cancer syndromes in the Netherlands.
Dommering CJ; Henneman L; van der Hout AH; Jonker MA; Tops CM; van den Ouweland AM; van der Luijt RB; Mensenkamp AR; Hogervorst FB; Redeker EJ; de Die-Smulders CE; Moll AC; Meijers-Heijboer H
Fam Cancer; 2017 Apr; 16(2):271-277. PubMed ID: 27826806
[TBL] [Abstract] [Full Text] [Related]
9. Outcome of triple negative breast cancer: comparison of sporadic and Brca1-associated cancers.
Tung N; Gaughan E; Hacker MR; Lee LJ; Alexander B; Poles E; Schnitt SJ; Garber JE
Breast Cancer Res Treat; 2014 Jul; 146(1):175-82. PubMed ID: 24839033
[TBL] [Abstract] [Full Text] [Related]
10. [Structural and functional analysis of tumor genomes and the development of test systems for early diagnosis, prognosis and cancer therapy optimization].
Zaletaev DV; Strel'nikov VV; Nemtsova MV; Babenko OV; Kuznetsova EB; Zemliakova VV; Kekeeva TV; Mikhaĭlenko DS; Tanas AS; Rudenko VV; Babaian AIu; Alekseeva EA; Simonova OA
Vestn Ross Akad Med Nauk; 2013; (9):7-14. PubMed ID: 24624866
[TBL] [Abstract] [Full Text] [Related]
11. Mendelian genetics of rare--and not so rare--cancers.
Eng C
Ann N Y Acad Sci; 2010 Dec; 1214():70-82. PubMed ID: 20946573
[TBL] [Abstract] [Full Text] [Related]
12. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract] [Full Text] [Related]
